Pharmaceutical Industry Information Portal

HomeRegulatory News

Regulatory News

Nuvaxovid is the first protein-based COVID-19 vaccine authorized in UK

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Medicines and Healthcare products...

Rosselkhoznadzor removed the veterinary drug “Telazol 100 mg” from the list of prohibited

Rosselkhoznadzor announced that a veterinary drug Telazol 100 mg has been allowed to be imported into Russia. The decision comes after Rosselkhoznadzor has confirmed the...

U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib)

AbbVie announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of moderate to severe atopic dermatitis in adults...

Pfizer Covid Pill Europe’s First Approved Oral Treatment Against Covid

Pfizer announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending the...

FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant

The following is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. As we have throughout the COVID-19 pandemic,...

Australia has recognized Russia’s Sputnik V COVID-19 vaccine for international travellers

International travellers who have had two doses of the Russian Sputnik V vaccine will be permitted to enter Australia now that the Therapeutic Goods...
spot_img

Expert Articles

spot_img